期刊文献+

化疗在肺癌综合治疗中的作用 被引量:1

The Role of Chemotherapy in Multidiplinary Treatment of Lung Cancer
暂未订购
导出
摘要 随着有效新药的发展 ,防治化疗不良反应等辅助治疗的进步 ,化学药物治疗晚期非小细胞肺癌 ,特别是小细胞肺癌疗效明显提高 ,因而 ,在肺癌的综合治疗中有不可取代的功能。其应用 :治疗局部晚期或有播散性病变及复发患者 ;新辅助化疗 ;辅助化疗 ;化学预防。 With the development of novel active agents and the adjuvant therapy progress of preventing on adverse effect,the response rate of chemotherapy in advanced non-small cell lung cancer has been elevated obviously,especially in small cell lung cancer.Therefore,the effect of chemotherapy with combined modality for lung cancer is not alterative.Its application for:The treatment of locally advanced or disseminated disease and recurrent patients;Neoadjuvant chemotherapy;Adjuvant chemotherapy;Chemoprevention.We focus on its treatment principles and new mothods combined with clinical practice and data.
作者 王肇炎
机构地区 湖南省肿瘤医院
出处 《中国肿瘤》 CAS 2001年第2期90-92,共3页 China Cancer
关键词 肺肿瘤 化疗 非小细胞肺癌 综合疗法 治疗 lung neoplasms chemotherapy small-cell lung cancer non-small-cell lung cancer comprehensive therapy
  • 相关文献

参考文献3

二级参考文献3

共引文献315

同被引文献7

  • 1Kim YH,Mishima M.Second-line chemotherapy for small-cell lungcancer(SCLC)[J].Cancer Treat Rev,2011,37(2):143-150.
  • 2Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecan plus cisplatincompared with etoposide plus cisplatin for extensive small-cell lungcancer[J].N Engl J Med,2002,346(2):85-91.
  • 3Lara PN Jr,Natale R,Crowley J,et al.Phase Ⅲ trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer:clinical and pharmacogenomic results from SWOGS0124[J].J Clin Oncol,2009,27(15):2530-2535.
  • 4Zatloukal P,Cardenal F,Szczesna A,et al.A multicenter internationalrandomized phaseⅢ study comparing Cisplatin in combination withIrinotecan or Etoposide in previously untreated small-cell lung can-cer patients with extensive disease[J].Ann Oncol,2010,12(9):1810-1816.
  • 5Groen HJ,Fokkema E,Biesma B,et al.Paclitaxel and carboplatin inthe treatment of small-cell lung cancer patients resistant to cyclop -hosphamide,doxorubicin,and etoposide:a non-cross-resistant sched -ule[J].J Clin Oncol,1999,17(3):927-932.
  • 6Ramalingam SS,Foster J,Gooding W,et al.Phase 2 study of irinote-can and paclitaxel in patients with recurrent or refractory small celllung cancer[J].Cancer,2010,116(5):1344-1349.
  • 7芮萌,刘长庭,段蕴铀,于晓妉,侯春梅.紫杉醇对p53突变型肺癌细胞株H322的生长抑制作用[J].现代肿瘤医学,2008,16(6):900-903. 被引量:2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部